Global Non-Ionic Contrast Agent 麻豆原创 Research Report 2025

Publication ID:

PB502255481

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Non-Ionic Contrast Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Non-ionic contrast agent is a type of radiographic contrast agent used in medical imaging procedures to enhance the visibility of blood vessels, organs, and tissues during various diagnostic imaging studies. Non-ionic contrast agents are widely used in computed tomography (CT) scans, magnetic resonance imaging (MRI), and other radiological examinations.
North American market for Non-Ionic Contrast Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-Ionic Contrast Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-Ionic Contrast Agent include GE Healthcare, Philips, Medtronic, Bayer, Bracco S.p.A., Guerbet, Lantheus, Hengrui Medicine, BeiLu Pharma, Sanochemia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-Ionic Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Ionic Contrast Agent.
The Non-Ionic Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Ionic Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Ionic Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GE Healthcare
Philips
Medtronic
Bayer
Bracco S.p.A.
Guerbet
Lantheus
Hengrui Medicine
BeiLu Pharma
Sanochemia
YRPG
Daiichi Sankyo
Takeda
Grupo Juste
Fuji Pharma
Segment by Type
Iohexol
Iodixanol
Iopamidol
Ioversol
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Ionic Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Ionic Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-Ionic Contrast Agent 麻豆原创 Overview
1.1 Product Definition
1.2 Non-Ionic Contrast Agent by Type
1.2.1 Global Non-Ionic Contrast Agent 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Iohexol
1.2.3 Iodixanol
1.2.4 Iopamidol
1.2.5 Ioversol
1.2.6 Others
1.3 Non-Ionic Contrast Agent by Application
1.3.1 Global Non-Ionic Contrast Agent 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Non-Ionic Contrast Agent 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Non-Ionic Contrast Agent Revenue 2020-2031
1.4.2 Global Non-Ionic Contrast Agent Sales 2020-2031
1.4.3 Global Non-Ionic Contrast Agent 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-Ionic Contrast Agent 麻豆原创 Competition by Manufacturers
2.1 Global Non-Ionic Contrast Agent Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Non-Ionic Contrast Agent Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Non-Ionic Contrast Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-Ionic Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Ionic Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Ionic Contrast Agent, Product Type & Application
2.7 Global Key Manufacturers of Non-Ionic Contrast Agent, Date of Enter into This Industry
2.8 Global Non-Ionic Contrast Agent 麻豆原创 Competitive Situation and Trends
2.8.1 Global Non-Ionic Contrast Agent 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Ionic Contrast Agent Players 麻豆原创 Share by Revenue
2.8.3 Global Non-Ionic Contrast Agent 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Ionic Contrast Agent 麻豆原创 Scenario by Region
3.1 Global Non-Ionic Contrast Agent 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-Ionic Contrast Agent Sales by Region: 2020-2031
3.2.1 Global Non-Ionic Contrast Agent Sales by Region: 2020-2025
3.2.2 Global Non-Ionic Contrast Agent Sales by Region: 2026-2031
3.3 Global Non-Ionic Contrast Agent Revenue by Region: 2020-2031
3.3.1 Global Non-Ionic Contrast Agent Revenue by Region: 2020-2025
3.3.2 Global Non-Ionic Contrast Agent Revenue by Region: 2026-2031
3.4 North America Non-Ionic Contrast Agent 麻豆原创 Facts & Figures by Country
3.4.1 North America Non-Ionic Contrast Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-Ionic Contrast Agent Sales by Country (2020-2031)
3.4.3 North America Non-Ionic Contrast Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Ionic Contrast Agent 麻豆原创 Facts & Figures by Country
3.5.1 Europe Non-Ionic Contrast Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-Ionic Contrast Agent Sales by Country (2020-2031)
3.5.3 Europe Non-Ionic Contrast Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Ionic Contrast Agent 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Non-Ionic Contrast Agent 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-Ionic Contrast Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-Ionic Contrast Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Ionic Contrast Agent 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Non-Ionic Contrast Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-Ionic Contrast Agent Sales by Country (2020-2031)
3.7.3 Latin America Non-Ionic Contrast Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Ionic Contrast Agent 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Non-Ionic Contrast Agent 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-Ionic Contrast Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-Ionic Contrast Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Ionic Contrast Agent Sales by Type (2020-2031)
4.1.1 Global Non-Ionic Contrast Agent Sales by Type (2020-2025)
4.1.2 Global Non-Ionic Contrast Agent Sales by Type (2026-2031)
4.1.3 Global Non-Ionic Contrast Agent Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Non-Ionic Contrast Agent Revenue by Type (2020-2031)
4.2.1 Global Non-Ionic Contrast Agent Revenue by Type (2020-2025)
4.2.2 Global Non-Ionic Contrast Agent Revenue by Type (2026-2031)
4.2.3 Global Non-Ionic Contrast Agent Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Non-Ionic Contrast Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-Ionic Contrast Agent Sales by Application (2020-2031)
5.1.1 Global Non-Ionic Contrast Agent Sales by Application (2020-2025)
5.1.2 Global Non-Ionic Contrast Agent Sales by Application (2026-2031)
5.1.3 Global Non-Ionic Contrast Agent Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Non-Ionic Contrast Agent Revenue by Application (2020-2031)
5.2.1 Global Non-Ionic Contrast Agent Revenue by Application (2020-2025)
5.2.2 Global Non-Ionic Contrast Agent Revenue by Application (2026-2031)
5.2.3 Global Non-Ionic Contrast Agent Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Non-Ionic Contrast Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Non-Ionic Contrast Agent Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Philips
6.2.1 Philips Company Information
6.2.2 Philips Description and Business Overview
6.2.3 Philips Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Philips Non-Ionic Contrast Agent Product Portfolio
6.2.5 Philips Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Non-Ionic Contrast Agent Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Non-Ionic Contrast Agent Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Bracco S.p.A.
6.5.1 Bracco S.p.A. Company Information
6.5.2 Bracco S.p.A. Description and Business Overview
6.5.3 Bracco S.p.A. Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bracco S.p.A. Non-Ionic Contrast Agent Product Portfolio
6.5.5 Bracco S.p.A. Recent Developments/Updates
6.6 Guerbet
6.6.1 Guerbet Company Information
6.6.2 Guerbet Description and Business Overview
6.6.3 Guerbet Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Guerbet Non-Ionic Contrast Agent Product Portfolio
6.6.5 Guerbet Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lantheus Non-Ionic Contrast Agent Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Company Information
6.8.2 Hengrui Medicine Description and Business Overview
6.8.3 Hengrui Medicine Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hengrui Medicine Non-Ionic Contrast Agent Product Portfolio
6.8.5 Hengrui Medicine Recent Developments/Updates
6.9 BeiLu Pharma
6.9.1 BeiLu Pharma Company Information
6.9.2 BeiLu Pharma Description and Business Overview
6.9.3 BeiLu Pharma Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BeiLu Pharma Non-Ionic Contrast Agent Product Portfolio
6.9.5 BeiLu Pharma Recent Developments/Updates
6.10 Sanochemia
6.10.1 Sanochemia Company Information
6.10.2 Sanochemia Description and Business Overview
6.10.3 Sanochemia Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanochemia Non-Ionic Contrast Agent Product Portfolio
6.10.5 Sanochemia Recent Developments/Updates
6.11 YRPG
6.11.1 YRPG Company Information
6.11.2 YRPG Description and Business Overview
6.11.3 YRPG Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 YRPG Non-Ionic Contrast Agent Product Portfolio
6.11.5 YRPG Recent Developments/Updates
6.12 Daiichi Sankyo
6.12.1 Daiichi Sankyo Company Information
6.12.2 Daiichi Sankyo Description and Business Overview
6.12.3 Daiichi Sankyo Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Daiichi Sankyo Non-Ionic Contrast Agent Product Portfolio
6.12.5 Daiichi Sankyo Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Company Information
6.13.2 Takeda Description and Business Overview
6.13.3 Takeda Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda Non-Ionic Contrast Agent Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Grupo Juste
6.14.1 Grupo Juste Company Information
6.14.2 Grupo Juste Description and Business Overview
6.14.3 Grupo Juste Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Grupo Juste Non-Ionic Contrast Agent Product Portfolio
6.14.5 Grupo Juste Recent Developments/Updates
6.15 Fuji Pharma
6.15.1 Fuji Pharma Company Information
6.15.2 Fuji Pharma Description and Business Overview
6.15.3 Fuji Pharma Non-Ionic Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Fuji Pharma Non-Ionic Contrast Agent Product Portfolio
6.15.5 Fuji Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Ionic Contrast Agent Industry Chain Analysis
7.2 Non-Ionic Contrast Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Ionic Contrast Agent Production Mode & Process Analysis
7.4 Non-Ionic Contrast Agent Sales and 麻豆原创ing
7.4.1 Non-Ionic Contrast Agent Sales Channels
7.4.2 Non-Ionic Contrast Agent Distributors
7.5 Non-Ionic Contrast Agent Customer Analysis
8 Non-Ionic Contrast Agent 麻豆原创 Dynamics
8.1 Non-Ionic Contrast Agent Industry Trends
8.2 Non-Ionic Contrast Agent 麻豆原创 Drivers
8.3 Non-Ionic Contrast Agent 麻豆原创 Challenges
8.4 Non-Ionic Contrast Agent 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GE Healthcare
Philips
Medtronic
Bayer
Bracco S.p.A.
Guerbet
Lantheus
Hengrui Medicine
BeiLu Pharma
Sanochemia
YRPG
Daiichi Sankyo
Takeda
Grupo Juste
Fuji Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.